Keith Katkin, President and CEO at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 195,300 shares at $4.08 ($797K) on 2010-12-02, disclosed to the SEC on 2010-12-03.
Open-market sale of $797k AVNR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SNDX | BUY | 2025-05-19 | $91K | — | Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |